{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have highlighted the critical role of miR‐509 (primarily the 5p form) as a modulator of oncogenic networks in diverse malignancies. In renal cell carcinoma, investigation into miR‐509‑5p established its relevance in tumor biology (‑."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In cervical cancer and hepatocellular carcinoma, miR‑509‑5p is transcriptionally activated by p53 and, in turn, downregulates MDM2, thereby suppressing cell growth and invasive behaviors (‑."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " In breast cancer, decreased miR‑509 expression in brain metastatic lesions correlates with dysregulation of the RhoC–TNF‑α network, which facilitates brain invasion (‑."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Moreover, early analyses in non‐small cell lung cancer (NSCLC) have begun to elucidate its involvement in modulating tumor cell properties (‑"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ", and studies in triple‑negative breast cancer further demonstrate that restoring miR‑509 levels not only inhibits proliferation and migration but also induces apoptosis through modulation of TNF‑α (‑."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFurther functional studies reveal that in NSCLC miR‑509‑5p exerts tumor‐suppressive effects by targeting factors such as YWHAG, leading to reduced Akt phosphorylation and decreased cell migration and invasion (‑."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " In prostate cancer, an inverse correlation between miR‑509‑5p and MDM2 expression has been reported, supporting its role in dampening tumor aggressiveness (‑."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " In pancreatic cancer, enforced miR‑509‑5p expression suppresses the epithelial–mesenchymal transition (EMT) by upregulating E‑cadherin and downregulating EMT‑related genes, thereby enhancing chemosensitivity (‑."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " Consistent with these observations, additional studies in breast cancer have implicated miR‑509‑5p in restraining cell growth and metastasis (‑"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": ", and in ovarian cancer, modulation of miR‑509‑3p affects cisplatin‐triggered apoptosis, suggesting a role in determining chemosensitivity (‑."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its mechanistic contributions to tumor suppression, miR‑509 has emerged as a promising prognostic biomarker. In pediatric acute myeloid leukemia, elevated miR‑509 levels form part of a miRNA signature that independently predicts poorer overall survival (‑."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": " In colon cancer, miR‑509‑3‑5p has been shown to interact with targets such as GTSE1, highlighting its tumor‐suppressive potential (‑."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": " In hepatocellular carcinoma, emerging data suggest that miR‑509 expression may serve as a useful diagnostic and prognostic indicator (‑"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": ", while in colorectal cancer, miR‑509‑5p is increasingly recognized for its role in modulating key oncogenic pathways (‑."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "W-B Zhang, Z-Q Pan, Q-S Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor suppressive miR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ir J Med Sci (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11845-013-0941-y"}], "href": "https://doi.org/10.1007/s11845-013-0941-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23619562"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23619562"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Z-J Ren, X-Y Nong, Y-R Lv, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mir-509-5p joins the Mdm2/p53 feedback loop and regulates cancer cell growth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2014.327"}], "href": "https://doi.org/10.1038/cddis.2014.327"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25144722"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25144722"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "F Xing, S Sharma, Y Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-α."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2014.412"}], "href": "https://doi.org/10.1038/onc.2014.412"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25659578"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25659578"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Ning Ma, Weihua Zhang, Chenhui Qiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Tumor Suppressive Role of MiRNA-509-5p by Targeting FOXM1 in Non-Small Cell Lung Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000443086"}], "href": "https://doi.org/10.1159/000443086"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27035590"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27035590"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Guoqiang Zhang, Zengyan Liu, Yong Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of miR-509 Increases Apoptosis and Inhibits Invasion via Suppression of Tumor Necrosis Factor-α in Triple-Negative Breast Cancer Hs578T Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3727/096504016X14648701447977"}], "href": "https://doi.org/10.3727/096504016X14648701447977"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27656833"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27656833"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Peng Wang, Yu Deng, XiangNing Fu "}, {"type": "b", "children": [{"type": "t", "text": "MiR-509-5p suppresses the proliferation, migration, and invasion of non-small cell lung cancer by targeting YWHAG."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2016.11.136"}], "href": "https://doi.org/10.1016/j.bbrc.2016.11.136"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27894843"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27894843"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "X M Tian, Y Z Luo, P He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of invasion and migration of prostate cancer cells by miRNA-509-5p via targeting MDM2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genet Mol Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4238/gmr16019195"}], "href": "https://doi.org/10.4238/gmr16019195"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28252164"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28252164"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Hidekazu Hiramoto, Tomoki Muramatsu, Daisuke Ichikawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-04191-w"}], "href": "https://doi.org/10.1038/s41598-017-04191-w"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28638102"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28638102"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Y-H Song, J Wang, G Nie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-509-5p functions as an anti-oncogene in breast cancer via targeting SOD2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2017)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28925482"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28925482"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Wei Chen, Jingjie Du, Xiaodi Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-509-3p promotes cisplatin-induced apoptosis in ovarian cancer cells through the regulation of anti-apoptotic genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenomics (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/pgs-2017-0115"}], "href": "https://doi.org/10.2217/pgs-2017-0115"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29173002"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29173002"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Ruiqi Zhu, Wenyi Lin, Weiwei Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A 4-microRNA signature for survival prognosis in pediatric and adolescent acute myeloid leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.27679"}], "href": "https://doi.org/10.1002/jcb.27679"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30242879"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30242879"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Ke Li "}, {"type": "b", "children": [{"type": "t", "text": "MiR-509-3-5p inhibits colon cancer malignancy by suppressing GTSE1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2021.07.008"}], "href": "https://doi.org/10.1016/j.bbrc.2021.07.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34284144"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34284144"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Guisen Dai, Shaoxin Shen, Yongsheng Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of miR-187 and miR-509-3p in serum of primary hepatocellular carcinoma patients and its evaluation of prognosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J BUON (2021)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34564990"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34564990"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Mahmoud A Elrebehy, Tamer M Abdelghany, Mostafa M Elshafey, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-509-5p promotes colorectal cancer cell ferroptosis by targeting SLC7A11."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Res Pract (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.prp.2023.154557"}], "href": "https://doi.org/10.1016/j.prp.2023.154557"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37229918"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37229918"}]}]}]}